FTC Announces Annual Update to HSR Thresholds
Client Alert | 2 min read | 01.24.24
The Federal Trade Commission announced its annual updates to the thresholds and filing fees related to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) on Monday. These dollar thresholds are indexed annually based on changes in the U.S. gross national product and the Consumer Price Index.
The HSR Act requires that certain transactions be notified prior to their consummation. This year, the “size-of-transaction" threshold for reporting mergers and acquisitions under the HSR Act will increase from $111.4 million to $119.5 million. In addition, the "size-of-person" threshold, the filing fee thresholds, and the fee schedule will all also increase. The new filing fee thresholds and fee schedule are as follows:
2024 Filing Fee |
2024 Size of Transaction |
|
$30,000 |
Less than $173.3 million |
|
$105,000 |
Not less than $173.3 million but less than $536.5 million |
|
$260,000 |
Not less than $536.5 million but less than $1.073 billion |
|
$415,000 |
Not less than $1.073 billion but less than $2.146 billion |
|
$830,000 |
Not less than $2.146 billion but less than $5.365 billion |
|
$2,335,000 |
$5.365 billion or more |
All of these revised thresholds will become effective thirty days after their publication in the Federal Register, which is expected in the next few days. Click here to read a full copy of the Commission's announcement, including a complete listing of the revised thresholds.
Contacts
Counsel
She/Her/Hers
Insights
Client Alert | 8 min read | 06.30.25
AI Companies Prevail in Path-Breaking Decisions on Fair Use
Last week, artificial intelligence companies won two significant copyright infringement lawsuits brought by copyright holders, marking an important milestone in the development of the law around AI. These decisions – Bartz v. Anthropic and Kadrey v. Meta (decided on June 23 and 25, 2025, respectively), along with a February 2025 decision in Thomson Reuters v. ROSS Intelligence – suggest that AI companies have plausible defenses to the intellectual property claims that have dogged them since generative AI technologies became widely available several years ago. Whether AI companies can, in all cases, successfully assert that their use of copyrighted content is “fair” will depend on their circumstances and further development of the law by the courts and Congress.
Client Alert | 3 min read | 06.30.25
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
